Haedoxan A



Compound IDCDAMM01519
Common nameHaedoxan A
IUPAC name6-[3-(1,3-benzodioxol-5-yl)-6-methoxy-2-(methoxymethyl)-2,3-dihydro-1,4-benzodioxin-7-yl]-3-[(4,6-dimethoxy-1,3-benzodioxol-5-yl)oxy]-3,4,6,6a-tetrahydro-1H-furo[3,4-c]furan-3a-ol
Molecular formulaC33H34O14

Experimental data

Retention time7.53
Adduct[M+H]+
Actual mz655.201
Theoretical mz655.202
Error2.1
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.2642

Identifiers and class information

Inchi keySVQIUEXUTJVJTM-UBUOSFEXNA-N
SmilesOC12COC(C=3C=C4OC(COC)C(OC4=CC3OC)C5=CC=C6OCOC6=C5)C2COC1OC7=C(OC)C=C8OCOC8=C7OC
SuperclassOrganoheterocyclic compounds
ClassBenzodioxanes

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)8
Number of reactive functional groups (#rtvFG)3
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)654.623
Computed dipole moment(dipole)2.511
Total solvent accessible surface area (SASA)901.276
Hydrophobic component of SASA (FOSA)643.503
Hydrophilic component of SASA (FISA)26.407
Pie component of the SASA (PISA)231.366
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1750.79
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)13.35
Free energy of solvation of dipole (dip^2/V)0.003602
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0148123
Globularity descriptor (glob)0.779463
Predicted polarizability in cubic angstroms (QPpolrz)60.985
Predicted hexadecane/gas partition coefficient (QPlogPC16)16.575
Predicted octanol/gas partition coefficient (QPlogPoct)28.592
Predicted water/gas partition coefficient (QPlogPw)16.491
Predicted octanol/water partition coefficient (QPlogPo/w)4.661
Predicted aqueous solubility (QPlogS)-6.083
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.587
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.204
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)5565.19
Predicted brain/blood partition coefficient (QPlogBB)-0.208
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)3163.2
Predicted skin permeability, log Kp (QPlogKp)-0.423
PM3 calculated ionization potential (IP(ev))8.529
PM3 calculated electron affinity (EA(eV))0.062
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)0.248
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)95.358
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)124.424
Number of nitrogen and oxygen atoms (#NandO)14
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P25101EDNRAEndothelin receptor ET-AT23499SEA
P24530EDNRBEndothelin receptor ET-BT92828SEA
P51843NR0B1Orphan nuclear receptor DAX-1T23191SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T23499DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P25101EDNRA
T23499DI0356Pulmonary hypertension[ICD-11: BB01]P25101EDNRA
T23499DI0425Urinary system clinical symptom[ICD-11: MF8Y]P25101EDNRA
T92828DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P24530EDNRB
T92828DI0356Pulmonary hypertension[ICD-11: BB01]P24530EDNRB

Copyright © 2025